{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:10:16Z","timestamp":1790230216586,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY027749"],"award-info":[{"award-number":["R01EY027749"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R24EY028764"],"award-info":[{"award-number":["R24EY028764"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R24EY028764-01A1S1"],"award-info":[{"award-number":["R24EY028764-01A1S1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R43EY031238"],"award-info":[{"award-number":["R43EY031238"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R43EY031643"],"award-info":[{"award-number":["R43EY031643"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R41EY027665"],"award-info":[{"award-number":["R41EY027665"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["1-18-IBS-172"],"award-info":[{"award-number":["1-18-IBS-172"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00018-021-04111-2","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T05:02:30Z","timestamp":1641790950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-883X","authenticated-orcid":false,"given":"Chang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5806-9578","authenticated-orcid":false,"given":"Prabuddha","family":"Waduge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-7942","authenticated-orcid":false,"given":"Liyang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Zuniga-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iok-Hou","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanfang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-8764","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"4111_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","volume":"27","author":"AS Chung","year":"2011","unstructured":"Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563\u2013584. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154002","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4111_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/138161212799040367","volume":"18","author":"T Shimizu","year":"2012","unstructured":"Shimizu T, Hoshino Y, Miyazaki H, Sato E (2012) Angiogenesis and microvasculature in the female reproductive organs: physiological and pathological implications. Curr Pharm Des 18:303\u2013309. https:\/\/doi.org\/10.2174\/138161212799040367","journal-title":"Curr Pharm Des"},{"key":"4111_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1387\/ijdb.103213sp","volume":"55","author":"S Patel-Hett","year":"2011","unstructured":"Patel-Hett S, D\u2019Amore PA (2011) Signal transduction in vasculogenesis and developmental angiogenesis. Int J Dev Biol 55:353\u2013363. https:\/\/doi.org\/10.1387\/ijdb.103213sp","journal-title":"Int J Dev Biol"},{"key":"4111_CR4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fonc.2019.01399","volume":"9","author":"D Aguilar-Cazares","year":"2019","unstructured":"Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A et al (2019) Contribution of Angiogenesis to Inflammation and Cancer. Front Oncol 9:1399. https:\/\/doi.org\/10.3389\/fonc.2019.01399","journal-title":"Front Oncol"},{"key":"4111_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA (2015) Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 49:67\u201381. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.002","journal-title":"Prog Retin Eye Res"},{"key":"4111_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43:245\u2013269. https:\/\/doi.org\/10.1016\/s0039-6257(98)00035-6","journal-title":"Surv Ophthalmol"},{"key":"4111_CR7","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1073\/pnas.1301331110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang Y, Zhang Y, Cao Z et al (2013) Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci USA 110:12018\u201312023. https:\/\/doi.org\/10.1073\/pnas.1301331110","journal-title":"Proc Natl Acad Sci USA"},{"key":"4111_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00228-012-1232-7","volume":"68","author":"S Taugourdeau-Raymond","year":"2012","unstructured":"Taugourdeau-Raymond S, Rouby F, Default A et al (2012) Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database. Eur J Clin Pharmacol 68:1103\u20131107. https:\/\/doi.org\/10.1007\/s00228-012-1232-7","journal-title":"Eur J Clin Pharmacol"},{"key":"4111_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41581-020-0260-2","volume":"16","author":"K Tanabe","year":"2020","unstructured":"Tanabe K, Wada J, Sato Y (2020) Targeting angiogenesis and lymphangiogenesis in kidney disease. Nat Rev Nephrol 16:289\u2013303. https:\/\/doi.org\/10.1038\/s41581-020-0260-2","journal-title":"Nat Rev Nephrol"},{"key":"4111_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LEH, Dammann O (2013) Retinopathy of prematurity. Lancet 382:1445\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(13)60178-6","journal-title":"Lancet"},{"key":"4111_CR11","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.3390\/ijms22094809","volume":"22","author":"C Dai","year":"2021","unstructured":"Dai C, Webster KA, Bhatt A et al (2021) Concurrent physiological and pathological angiogenesis in retinopathy of prematurity and emerging therapies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094809","journal-title":"Int J Mol Sci"},{"key":"4111_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1084\/jem.20161802","volume":"214","author":"ME LeBlanc","year":"2017","unstructured":"LeBlanc ME, Wang W, Chen X et al (2017) Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy. J Exp Med 214:1029\u20131047. https:\/\/doi.org\/10.1084\/jem.20161802","journal-title":"J Exp Med"},{"key":"4111_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exer.2019.03.009","volume":"182","author":"X Rong","year":"2019","unstructured":"Rong X, Tian H, Yang L, Li W (2019) Function-first ligandomics for ocular vascular research and drug target discovery. Exp Eye Res 182:57\u201364. https:\/\/doi.org\/10.1016\/j.exer.2019.03.009","journal-title":"Exp Eye Res"},{"key":"4111_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.exer.2019.01.009","volume":"181","author":"ME LeBlanc","year":"2019","unstructured":"LeBlanc ME, Wang W, Ji Y et al (2019) Secretogranin III as a novel target for the therapy of choroidal neovascularization. Exp Eye Res 181:120\u2013126. https:\/\/doi.org\/10.1016\/j.exer.2019.01.009","journal-title":"Exp Eye Res"},{"key":"4111_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10456-019-09662-4","volume":"22","author":"F Tang","year":"2019","unstructured":"Tang F, LeBlanc ME, Wang W et al (2019) Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Angiogenesis 22:369\u2013382. https:\/\/doi.org\/10.1007\/s10456-019-09662-4","journal-title":"Angiogenesis"},{"key":"4111_CR16","doi-asserted-by":"publisher","first-page":"e22106","DOI":"10.1096\/fj.202101085RR","volume":"36","author":"L Ji","year":"2022","unstructured":"Ji L, Waduge P, Hao L et al (2022) Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB J 36:e22106. https:\/\/doi.org\/10.1096\/fj.202101085RR","journal-title":"FASEB J."},{"key":"4111_CR17","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.2353\/ajpath.2010.100526","volume":"177","author":"A Stahl","year":"2010","unstructured":"Stahl A, Chen J, Sapieha P et al (2010) Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol 177:2715\u20132723. https:\/\/doi.org\/10.2353\/ajpath.2010.100526","journal-title":"Am J Pathol"},{"key":"4111_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ et al (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4:1565\u20131573. https:\/\/doi.org\/10.1038\/nprot.2009.187","journal-title":"Nat Protoc"},{"key":"4111_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jmr.983","volume":"23","author":"NB Caberoy","year":"2010","unstructured":"Caberoy NB, Zhou Y, Jiang X et al (2010) Efficient identification of tubby-binding proteins by an improved system of T7 phage display. J Mol Recognit 23:74\u201383. https:\/\/doi.org\/10.1002\/jmr.983","journal-title":"J Mol Recognit"},{"key":"4111_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00018-017-2635-5","volume":"75","author":"W Li","year":"2018","unstructured":"Li W, Webster KA, LeBlanc ME, Tian H (2018) Secretogranin III: a diabetic retinopathy-selective angiogenic factor. Cell Mol Life Sci 75:635\u2013647. https:\/\/doi.org\/10.1007\/s00018-017-2635-5","journal-title":"Cell Mol Life Sci"},{"key":"4111_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1507\/endocrj.k10e-038","volume":"57","author":"M Hosaka","year":"2010","unstructured":"Hosaka M, Watanabe T (2010) Secretogranin III: a bridge between core hormone aggregates and the secretory granule membrane. Endocr J 57:275\u2013286. https:\/\/doi.org\/10.1507\/endocrj.k10e-038","journal-title":"Endocr J"},{"key":"4111_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.drudis.2018.01.013","volume":"23","author":"W Li","year":"2018","unstructured":"Li W, Pang I-H, Pacheco MTF, Tian H (2018) Ligandomics: a paradigm shift in biological drug discovery. Drug Discov Today 23:636\u2013643. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.013","journal-title":"Drug Discov Today"},{"key":"4111_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"EA Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED et al (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905\u2013909. https:\/\/doi.org\/10.1073\/pnas.92.3.905","journal-title":"Proc Natl Acad Sci USA"},{"key":"4111_CR24","doi-asserted-by":"publisher","first-page":"19679","DOI":"10.1038\/s41598-019-56298-x","volume":"9","author":"JE Kline","year":"2019","unstructured":"Kline JE, Illapani VSP, He L et al (2019) Retinopathy of prematurity and bronchopulmonary dysplasia are independent antecedents of cortical maturational abnormalities in very preterm infants. Sci Rep 9:19679. https:\/\/doi.org\/10.1038\/s41598-019-56298-x","journal-title":"Sci Rep"},{"key":"4111_CR25","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.1038\/s41598-020-68488-z","volume":"10","author":"N Froger","year":"2020","unstructured":"Froger N, Matonti F, Roubeix C et al (2020) VEGF is an autocrine\/paracrine neuroprotective factor for injured retinal ganglion neurons. Sci Rep 10:12409. https:\/\/doi.org\/10.1038\/s41598-020-68488-z","journal-title":"Sci Rep"},{"key":"4111_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/j.1460-2075.1990.tb08123.x","volume":"9","author":"DM Kingsley","year":"1990","unstructured":"Kingsley DM, Rinchik EM, Russell LB et al (1990) Genetic ablation of a mouse gene expressed specifically in brain. EMBO J 9:395\u2013399","journal-title":"EMBO J"},{"key":"4111_CR27","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1182\/blood-2012-04-396846","volume":"120","author":"P Sapieha","year":"2012","unstructured":"Sapieha P (2012) Eyeing central neurons in vascular growth and reparative angiogenesis. Blood 120:2182\u20132194. https:\/\/doi.org\/10.1182\/blood-2012-04-396846","journal-title":"Blood"},{"key":"4111_CR28","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1167\/iovs.13-13397","volume":"55","author":"CC Tokunaga","year":"2014","unstructured":"Tokunaga CC, Mitton KP, Dailey W et al (2014) Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 55:1884\u20131892. https:\/\/doi.org\/10.1167\/iovs.13-13397","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4111_CR29","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1073\/pnas.0605211103","volume":"103","author":"LC Liets","year":"2006","unstructured":"Liets LC, Eliasieh K, van der List DA, Chalupa LM (2006) Dendrites of rod bipolar cells sprout in normal aging retina. Proc Natl Acad Sci USA 103:12156\u201312160. https:\/\/doi.org\/10.1073\/pnas.0605211103","journal-title":"Proc Natl Acad Sci USA"},{"key":"4111_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/apm.2017.11.01","volume":"7","author":"C Johnstone","year":"2018","unstructured":"Johnstone C, Rich SE (2018) Bleeding in cancer patients and its treatment: a review. Ann Palliat Med 7:265\u2013273","journal-title":"Ann Palliat Med"},{"key":"4111_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","volume":"29","author":"A Laude","year":"2010","unstructured":"Laude A, Cackett PD, Vithana EN et al (2010) Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 29:19\u201329. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.10.001","journal-title":"Prog Retin Eye Res"},{"key":"4111_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10020-018-0038-1","volume":"24","author":"R Zhou","year":"2018","unstructured":"Zhou R, Zhang S, Gu X et al (2018) Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy. Mol Med 24:41. https:\/\/doi.org\/10.1186\/s10020-018-0038-1","journal-title":"Mol Med"},{"key":"4111_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay3566","author":"H Liu","year":"2020","unstructured":"Liu H, Mei FC, Yang W et al (2020) Epac1 inhibition ameliorates pathological angiogenesis through coordinated activation of Notch and suppression of VEGF signaling. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aay3566","journal-title":"Sci Adv"},{"key":"4111_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/glia.23543","volume":"67","author":"S Murinello","year":"2019","unstructured":"Murinello S, Usui Y, Sakimoto S et al (2019) miR-30a-5p inhibition promotes interaction of Fas+ endothelial cells and FasL+ microglia to decrease pathological neovascularization and promote physiological angiogenesis. Glia 67:332\u2013344. https:\/\/doi.org\/10.1002\/glia.23543","journal-title":"Glia"},{"key":"4111_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2006.07.003","volume":"10","author":"TL Phung","year":"2006","unstructured":"Phung TL, Ziv K, Dabydeen D et al (2006) Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 10:159\u2013170. https:\/\/doi.org\/10.1016\/j.ccr.2006.07.003","journal-title":"Cancer Cell"},{"key":"4111_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ccr.2012.01.004","volume":"21","author":"A Chaudhary","year":"2012","unstructured":"Chaudhary A, Hilton MB, Seaman S et al (2012) TEM8\/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell 21:212\u2013226. https:\/\/doi.org\/10.1016\/j.ccr.2012.01.004","journal-title":"Cancer Cell"},{"key":"4111_CR37","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1096\/fj.05-5565fje","volume":"20","author":"T Miyoshi","year":"2006","unstructured":"Miyoshi T, Hirohata S, Ogawa H et al (2006) Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice. FASEB J 20:1904\u20131906. https:\/\/doi.org\/10.1096\/fj.05-5565fje","journal-title":"FASEB J"},{"key":"4111_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda A, Baffi JZ, Kleinman ME et al (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460:225\u2013230. https:\/\/doi.org\/10.1038\/nature08151","journal-title":"Nature"},{"key":"4111_CR39","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.2337\/db16-1035","volume":"66","author":"JD Lam","year":"2017","unstructured":"Lam JD, Oh DJ, Wong LL et al (2017) Identification of RUNX1 as a mediator of aberrant retinal angiogenesis. Diabetes 66:1950\u20131956. https:\/\/doi.org\/10.2337\/db16-1035","journal-title":"Diabetes"},{"key":"4111_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI83427","volume":"126","author":"TA Al-Hilal","year":"2016","unstructured":"Al-Hilal TA, Chung SW, Choi JU et al (2016) Targeting prion-like protein doppel selectively suppresses tumor angiogenesis. J Clin Invest 126:1251\u20131266. https:\/\/doi.org\/10.1172\/JCI83427","journal-title":"J Clin Invest"},{"key":"4111_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1096\/fj.201600540R","volume":"31","author":"A Ridiandries","year":"2017","unstructured":"Ridiandries A, Tan JTM, Ravindran D et al (2017) CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis. FASEB J 31:1179\u20131192. https:\/\/doi.org\/10.1096\/fj.201600540R","journal-title":"FASEB J"},{"key":"4111_CR42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439\u2013442. https:\/\/doi.org\/10.1038\/380439a0","journal-title":"Nature"},{"key":"4111_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/376066a0","volume":"376","author":"GH Fong","year":"1995","unstructured":"Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66\u201370. https:\/\/doi.org\/10.1038\/376066a0","journal-title":"Nature"},{"key":"4111_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62\u201366. https:\/\/doi.org\/10.1038\/376062a0","journal-title":"Nature"},{"key":"4111_CR45","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1167\/iovs.10-6798","volume":"52","author":"GA Lutty","year":"2011","unstructured":"Lutty GA, McLeod DS, Bhutto I, Wiegand SJ (2011) Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Invest Ophthalmol Vis Sci 52:4039\u20134047. https:\/\/doi.org\/10.1167\/iovs.10-6798","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4111_CR46","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ophtha.2017.09.020","volume":"125","author":"RN Vogel","year":"2018","unstructured":"Vogel RN, Strampe M, Fagbemi OE et al (2018) Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity. Ophthalmology 125:444\u2013452. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.020","journal-title":"Ophthalmology"},{"key":"4111_CR47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3218","author":"J Morin","year":"2016","unstructured":"Morin J, Luu TM, Superstein R et al (2016) Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2015-3218","journal-title":"Pediatrics"},{"key":"4111_CR48","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato T, Kusaka S, Shimojo H, Fujikado T (2009) Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116:1599\u20131603. https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.023","journal-title":"Ophthalmology"},{"key":"4111_CR49","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487. https:\/\/doi.org\/10.1056\/NEJM199412013312203","journal-title":"N Engl J Med"},{"key":"4111_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/s1091-8531(98)90111-2","volume":"2","author":"DK Wallace","year":"1998","unstructured":"Wallace DK, Kylstra JA, Greenman DB, Freedman SF (1998) Significance of isolated neovascular tufts (\u201cpopcorn\u201d) in retinopathy of prematurity. J AAPOS 2:52\u201356. https:\/\/doi.org\/10.1016\/s1091-8531(98)90111-2","journal-title":"J AAPOS"},{"key":"4111_CR51","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1074\/jbc.271.10.5519","volume":"271","author":"H Gitay-Goren","year":"1996","unstructured":"Gitay-Goren H, Cohen T, Tessler S et al (1996) Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem 271:5519\u20135523. https:\/\/doi.org\/10.1074\/jbc.271.10.5519","journal-title":"J Biol Chem"},{"key":"4111_CR52","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","volume":"48","author":"ME Cooper","year":"1999","unstructured":"Cooper ME, Vranes D, Youssef S et al (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229\u20132239. https:\/\/doi.org\/10.2337\/diabetes.48.11.2229","journal-title":"Diabetes"},{"key":"4111_CR53","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/srep01932","volume":"3","author":"G Egawa","year":"2013","unstructured":"Egawa G, Nakamizo S, Natsuaki Y et al (2013) Intravital analysis of vascular permeability in mice using two-photon microscopy. Sci Rep 3:1932. https:\/\/doi.org\/10.1038\/srep01932","journal-title":"Sci Rep"},{"key":"4111_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/29.2.7252121","volume":"29","author":"RM Pino","year":"1981","unstructured":"Pino RM, Essner E (1981) Permeability of rat choriocapillaris to hemeproteins. Restriction of tracers by a fenestrated endothelium. J Histochem Cytochem 29:281\u2013290. https:\/\/doi.org\/10.1177\/29.2.7252121","journal-title":"J Histochem Cytochem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-04111-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-04111-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T07:25:37Z","timestamp":1645687537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-04111-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-04111-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"18 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HT and WL are shareholders of Everglades Biopharma, LLC and LigandomicsRx, LLC. The remaining authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were approved by the Institutional Animal Care and Use Committee at University of Miami and Baylor College of Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"63"}}